{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T10:55:30Z","timestamp":1791284130263,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.clinthera.2011.11.025","type":"journal-article","created":{"date-parts":[[2011,12,14]],"date-time":"2011-12-14T12:36:39Z","timestamp":1323866199000},"page":"239-249.e2","source":"Crossref","is-referenced-by-count":85,"title":["Prescription Drug Use in Pregnancy: A Retrospective, Population-Based Study in British Columbia, Canada (2001\u20132006)"],"prefix":"10.1016","volume":"34","author":[{"given":"Jamie R.","family":"Daw","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Mintzes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Law","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian E.","family":"Hanley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven G.","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2011.11.025_bib1","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S1526-9523(02)00335-5","article-title":"The drug development process and the pregnant woman","volume":"47","author":"Frederiksen","year":"2002","journal-title":"J Midwifery Womens Health"},{"key":"10.1016\/j.clinthera.2011.11.025_bib2","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/pds.2184","article-title":"Prescription drug use during pregnancy in developed countries: a systematic review","volume":"20","author":"Daw","year":"2011","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.clinthera.2011.11.025_bib3","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s002280050608","article-title":"Drug use in first pregnancy and lactation: a population-based survey among Danish women","volume":"55","author":"Olesen","year":"1999","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2011.11.025_bib4","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00228-003-0584-4","article-title":"Prescription drugs during pregnancy and lactation\u2014a Finnish register-based study","volume":"59","author":"Malm","year":"2003","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2011.11.025_bib5","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s00228-009-0647-2","article-title":"Prescription of drugs during pregnancy: a study using EFEMERIS, the new French database","volume":"65","author":"Lacroix","year":"2009","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2011.11.025_bib6","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s00228-004-0817-1","article-title":"Drug prescription in pregnancy: analysis of a large statutory sickness fund population","volume":"60","author":"Egen-Lappe","year":"2004","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2011.11.025_bib7","first-page":"9","article-title":"Medication use among pregnant women","volume":"17","author":"Garriguet","year":"2006","journal-title":"Health Rep"},{"key":"10.1016\/j.clinthera.2011.11.025_bib8","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.ajog.2004.04.025","article-title":"Prescription drug use in pregnancy","volume":"191","author":"Andrade","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.clinthera.2011.11.025_bib9","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1089\/jwh.2005.14.401","article-title":"Correlates of prescription drug use during pregnancy","volume":"14","author":"Riley","year":"2005","journal-title":"J Womens Health"},{"key":"10.1016\/j.clinthera.2011.11.025_bib10","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/0895-4356(93)90132-K","article-title":"Use of prescription and non-prescription drugs in pregnancy","volume":"46","author":"Rubin","year":"1993","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.clinthera.2011.11.025_bib11","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1111\/j.1471-0528.2009.02377.x","article-title":"Prescriptions filled during pregnancy for drugs with the potential of fetal harm","volume":"116","author":"Kulaga","year":"2009","journal-title":"Br J Obstet Gynecol"},{"key":"10.1016\/j.clinthera.2011.11.025_bib12","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/jp.2008.6","article-title":"Patterns of pregnancy exposure to prescription FDA C, D and X drugs in a Canadian population","volume":"28","author":"Wen","year":"2008","journal-title":"J Perinatol"},{"key":"10.1016\/j.clinthera.2011.11.025_bib13","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1097\/00007611-199705000-00006","article-title":"Prenatal use of medications by women giving birth at a university hospital","volume":"90","author":"Splinter","year":"1997","journal-title":"Southern Med J"},{"key":"10.1016\/j.clinthera.2011.11.025_bib14","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1365-3016.2003.00542.x","article-title":"Prescriptions for contraindicated category X drugs in pregnancy among women enrolled in TennCare","volume":"18","author":"Cooper","year":"2004","journal-title":"Paediatr Perinatal Epidemiol"},{"key":"10.1016\/j.clinthera.2011.11.025_bib16","first-page":"30832","article-title":"Content and format of labeling for human prescription drug and biological products; requirements for pregnancy and lactation labeling","volume":"73","year":"2008","journal-title":"Fed Reg"},{"key":"10.1016\/j.clinthera.2011.11.025_bib17","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S1701-2163(16)32668-8","article-title":"Principles of human teratology: drug, chemical and infectious exposure","volume":"29","author":"Wilson","year":"2007","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.clinthera.2011.11.025_bib18","first-page":"634","article-title":"Drug use in pregnancy: resources and recommendations","volume":"56","author":"Repchinsky","year":"2010","journal-title":"Can Fam Physician"},{"key":"10.1016\/j.clinthera.2011.11.025_bib19","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2165\/00002018-200023030-00006","article-title":"Risk classification systems for drug use during pregnancy: are they a reliable source of information?","volume":"23","author":"Addis","year":"2000","journal-title":"Drug Saf"},{"key":"10.1016\/j.clinthera.2011.11.025_bib21","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s00228-006-0119-x","article-title":"Associations between socio-economic factors and the use of prescription medication during pregnancy: a population-based study among 19,874 Danish women","volume":"62","author":"Olesen","year":"2006","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2011.11.025_bib22","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1007\/s00228-008-0546-y","article-title":"Prescription drug use during pregnancy: a population-based study in Regione Emilia-Romagna, Italy","volume":"64","author":"Gagne","year":"2008","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2011.11.025_bib23","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S1526-9523(02)00324-0","article-title":"Safe prescribing practices in pregnancy and lactation","volume":"47","author":"Hansen","year":"2002","journal-title":"J Midwifery Womens Health"},{"key":"10.1016\/j.clinthera.2011.11.025_bib24","doi-asserted-by":"crossref","first-page":"370","DOI":"10.7326\/0003-4819-147-6-200709180-00006","article-title":"Documentation of contraception and pregnancy when prescribing potentially teratogenic medications for reproductive-age women","volume":"147","author":"Schwarz","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clinthera.2011.11.025_bib25","doi-asserted-by":"crossref","first-page":"e579","DOI":"10.1016\/j.ajog.2009.06.061","article-title":"Risk of preterm delivery and other adverse perinatal outcomes in relation to maternal use of psychotropic medications during pregnancy","volume":"201","author":"Calderon-Margalit","year":"2009","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.clinthera.2011.11.025_bib26","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1002\/pds.1457","article-title":"Use of benzodiazepines and benzodiazepine receptor agonists during pregnancy: neonatal outcome and congenital malformations","volume":"16","author":"Wikner","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.clinthera.2011.11.025_bib27","series-title":"Drugs in Pregnancy and Lactation","author":"Briggs","year":"2008"},{"key":"10.1016\/j.clinthera.2011.11.025_bib28","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1002\/pds.1100","article-title":"Evaluation of gestational age and admission date assumptions used to determine prenatal drug exposure from administrative data","volume":"14","author":"Raebel","year":"2005","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.clinthera.2011.11.025_bib29","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1067\/mob.2002.125740","article-title":"Review of pregnancy labeling of prescription drugs: is the current system adequate to inform of risks?","volume":"187","author":"Doering","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.clinthera.2011.11.025_bib30","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2165\/00002018-199614020-00001","article-title":"Drugs during pregnancy: an issue of risk classification and information to prescribers","volume":"14","author":"Sannerstedt","year":"1996","journal-title":"Drug Saf"},{"key":"10.1016\/j.clinthera.2011.11.025_bib31","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/BF03161214","article-title":"FDA's proposed rule for pregnancy and lactation labeling: improving maternal child health through well-informed medicine use","volume":"4","author":"Feibus","year":"2008","journal-title":"J Med Toxicol"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291811007806?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291811007806?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T21:52:42Z","timestamp":1713217962000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291811007806"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S0149291811007806"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2011.11.025","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}